Advisortrust Partners’s West Pharmaceutical WST Stock Holding History

Advisortrust Partners’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$263K	Buy	+710	New	+$251K	0.08%	175

Other funds holding WST

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Advisortrust Partners's WST Position: Q3 2026 in Review

Advisortrust Partners opened a new position in West Pharmaceutical (WST) in Q3 2026: 710 shares worth $263K. The stake represents 0.08% of the portfolio and ranks #175 among its holdings.

515 funds tracked by Wall St. Rank hold WST as of Q3 2026.

Advisortrust Partners held 710 shares of West Pharmaceutical worth $263K as of Q3 2026.
West Pharmaceutical was a new Advisortrust Partners position in Q3 2026.
West Pharmaceutical made up 0.08% of Advisortrust Partners's portfolio in Q3 2026, its #175 holding.
515 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Advisortrust Partners's 13F filing for Q3 2026, filed 2 Nov 2026.